Skip to content

Drug interactions

Rivaroxaban + Rucaparib

Severity: Minor

Rivaroxaban and Rucaparib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rucaparib is a weak inhibitor of CYP3A4 and may slightly raise rivaroxaban exposure. This could modestly increase bleeding risk, particularly in patients with other risk factors such as renal impairment or thrombocytopenia from PARP inhibition.

What this interaction means in plain words

Rivaroxaban and Rucaparib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Rivaroxaban belongs to Cardiovascular; Rucaparib belongs to Oncology.

Evidence level: Low

Why it happens

Rucaparib weakly inhibits CYP3A4, reducing rivaroxaban clearance.

What to do

Monitor for bleeding and check blood counts regularly, since rucaparib can cause cytopenias. No empirical dose reduction is usually required.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Rivaroxaban and Rucaparib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Rivaroxaban with Rucaparib?

MediHelp rates the interaction as minor. Rivaroxaban and Rucaparib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Rucaparib is a weak inhibitor of CYP3A4 and may slightly raise rivaroxaban exposure. This could modestly increase bleeding risk, particularly in patients with other risk factors such as renal impairment or thrombocytopenia from PARP inhibition.

How serious is the interaction between Rivaroxaban and Rucaparib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for bleeding and check blood counts regularly, since rucaparib can cause cytopenias. No empirical dose reduction is usually required.

What other medicines interact with Rivaroxaban?

MediHelp also lists interactions of Rivaroxaban with, for example, Defibrotide, Ketoconazole, Ketorolac. The full list is on the Rivaroxaban page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in